News and Trends 20 Sep 2022
First treatment of rare kidney disease launched in Germany by STADA Arzneimittel
The first and only approved treatment for primary immunoglobin A (IgA) nephropathy, a rare, progressive disease of the kidneys, has been launched in Germany. European commercial partner of Calliditas Therapeutics…